drugset / Trial / NCT05527899

Zinc Intervention in Elderly for Prevention of Pneumonia

NCT05527899

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Pneumonia is a major public health problem for the elderly and is one of the leading causes of hospitalization and death for this population, particularly for elderly nursing home residents. This planning grants seeks to establish a safe and effective dose of zinc supplementation with the goal to conduct a larger randomized clinical trial to study the effect of zinc supplementation in nursing home elderly with low serum zinc levels on the risk, antibiotic use, and duration of sick days with pneumonia. This project has significant potential to positively impact the health and quality of life in the elderly and to reduce the economic costs associated with their care.

Timeline

Start
2022-05-03
Primary completion
2024-06-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc gluconate Small molecule 30 mg
Subject Zinc gluconate Small molecule 60 mg